# EDGAR Filing Document

**Accession Number:** 0001750284
**File Stem:** 0001193125-26-191960
**Filing Date:** 2026-4
**Character Count:** 2473
**Document Hash:** 74eb4885151585b11b0c2dda4df7719d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-191960.hdr.sgml**: 20260429

**ACCESSION NUMBER**: 0001193125-26-191960

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 11

**FILED AS OF DATE**: 20260429

**DATE AS OF CHANGE**: 20260429

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Olema Pharmaceuticals, Inc.
- **CENTRAL INDEX KEY:** 0001750284
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 300409740
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39712
- **FILM NUMBER:** 26916951

**BUSINESS ADDRESS:**
- **STREET 1:** 780 BRANNAN STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94103
- **BUSINESS PHONE:** (415) 651-3316

**MAIL ADDRESS:**
- **STREET 1:** 780 BRANNAN STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94103

?xml version='1.0' encoding='ASCII'? DEFA14A

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

SCHEDULE 14A **INFORMATION**

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

(Amendment No.)

---

| | | |
|:---|:---|:---|
| Filed by the Registrant | Filed by the Registrant | 🗹 |
| Filed by a Party other than the Registrant | Filed by a Party other than the Registrant | ☐ |
| Check the appropriate box: | Check the appropriate box: |  |
| ☐ | Preliminary Proxy Statement |  |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement | Definitive Proxy Statement |
| 🗹 | Definitive Additional Materials | Definitive Additional Materials |
| ☐ | Soliciting Material Pursuant to § 240.14a-12 | Soliciting Material Pursuant to § 240.14a-12 |

---

Olema Pharmaceuticals, Inc.

(Name of Registrant as Specified In Its Charter)

**N/A**

(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box)

---

| | |
|:---|:---|
| 🗹 | No fee required. |
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |

---

------

![img25451355_0.jpg](img25451355_0.jpg)

------

![img25451355_1.jpg](img25451355_1.jpg)

------